Accelerate Bio Podcast GLP-1: First Human Enhancement Drug? | Dr. Anant Vinjamoori
GLP-1s may be the first real human enhancement drug.
Dr. Anant Vinjamoori - longevity physician and healthtech entrepreneur - explains why GLP-1s matter far beyond weight loss, why they may be the first drug class seriously crossing into longevity medicine, and why they could be a wedge into next-gen peptides, programable biology, and AI-driven human upgrades.
Hosted by Mgoes → https://x.com/m_goes_distance
Brought to you by SuperHuman Fund → https://superhuman.fund/
---
0:00 - Health → Human Enhancement?
5:37 - GLP-1s: The Real Novelty
8:23 - Next Gen Drugs, Peptides
13:29 - Un*ucking Regulation
22:50 - Health Influencers & Hype
29:23 - Social Media vs AI Discovery
35:46 - GLP1s = Prozac?
41:35 - Biotech Is The Answer
48:19 - AI Drug Discovery
---
The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress.
---
This episode discusses GLP-1s, GLP-1 drugs, semaglutide, tirzepatide, longevity medicine, human enhancement, Dr Anant Vinjamoori, peptides, anti aging, healthspan, lifespan, metabolic health, obesity drugs, biotechnology, AI drug discovery, programmable biology, cell signaling, longevity biotech, future of healthcare, precision medicine.